Financial Snapshot

Revenue
$26.20M
TTM
Gross Margin
23.91%
TTM
Net Earnings
$651.5K
TTM
Current Assets
$22.15M
Q3 2023
Current Liabilities
$18.92M
Q3 2023
Current Ratio
117.07%
Q3 2023
Total Assets
$29.96M
Q3 2023
Total Liabilities
$20.08M
Q3 2023
Book Value
$9.876M
Q3 2023
Cash
$1.596M
Q3 2023
P/E
131.1
Nov 29, 2024 EST
Free Cash Flow
-$2.645M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021
Revenue $13.57M $19.71M $45.86M
YoY Change -31.18% -57.02%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021
Revenue $13.57M $19.71M $45.86M
Cost Of Revenue $9.423M $15.29M $37.22M
Gross Profit $4.143M $4.419M $8.639M
Gross Profit Margin 30.54% 22.42% 18.84%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021
Selling, General & Admin $3.429M $3.597M $4.485M
YoY Change -4.66% -19.82%
% of Gross Profit 82.77% 81.39% 51.92%
Research & Development $301.6K $183.9K $186.5K
YoY Change 64.02% -1.37%
% of Gross Profit 7.28% 4.16% 2.16%
Depreciation & Amortization $1.603M $3.258M $4.193M
YoY Change -50.8% -22.3%
% of Gross Profit 38.7% 73.74% 48.54%
Operating Expenses $3.731M $3.780M $4.672M
YoY Change -1.31% -19.08%
Operating Profit $412.2K $638.3K $3.967M
YoY Change -35.42% -83.91%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021
Interest Expense -$367.3K -$351.0K -$329.5K
YoY Change 4.65% 6.52%
% of Operating Profit -89.11% -54.99% -8.31%
Other Income/Expense, Net $65.49K $826.2K $3.706M
YoY Change -92.07% -77.71%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021
Pretax Income $110.4K $1.114M $7.344M
YoY Change -90.09% -84.84%
Income Tax $47.01K $169.4K $1.079M
% Of Pretax Income 42.59% 15.22% 14.69%
Net Earnings $112.0K $865.2K $5.958M
YoY Change -87.05% -85.48%
Net Earnings / Revenue 0.83% 4.39% 12.99%
Basic Earnings Per Share
Diluted Earnings Per Share $0.01 $0.06 $0.41

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021
Cash & Short-Term Investments $1.596M $731.2K $508.7K
YoY Change 118.29% 43.73%
Cash & Equivalents $1.596M $731.2K $508.7K
Short-Term Investments
Other Short-Term Assets $1.481M $684.6K $381.8K
YoY Change 116.33% 79.32%
Inventory $4.620M $4.358M $6.295M
Prepaid Expenses
Receivables $3.332M $3.288M $302.4K
Other Receivables $11.12M $7.549M $10.66M
Total Short-Term Assets $22.15M $16.61M $18.15M
YoY Change 33.36% -8.46%
Property, Plant & Equipment $6.741M $7.981M $11.45M
YoY Change -15.54% -30.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $66.87K
YoY Change
Total Long-Term Assets $7.806M $8.931M $12.51M
YoY Change -12.59% -28.61%
Total Assets $29.96M $25.54M $30.66M
YoY Change
Accounts Payable $3.962M $3.203M $9.044M
YoY Change 23.7% -64.59%
Accrued Expenses $2.064M $1.631M $428.0K
YoY Change 26.58% 281.0%
Deferred Revenue
YoY Change
Short-Term Debt $8.840M $5.975M $6.596M
YoY Change 47.97% -9.42%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.92M $14.26M $18.91M
YoY Change 32.73% -24.62%
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.13K $68.50K
YoY Change -26.82%
Total Long-Term Liabilities $50.13K $68.50K $0.00
YoY Change -26.82%
Total Liabilities $20.08M $15.54M $20.62M
YoY Change 29.23% -24.62%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $85.405 Million

About WORK Medical Technology Group LTD

Work Medical Technology Group Ltd is a CN-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 216 full-time employees. The company went IPO on 2024-08-23. Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The firm's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The firm principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.

Industry: Surgical & Medical Instruments & Apparatus Peers: